{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:01:54Z","timestamp":1773273714973,"version":"3.50.1"},"reference-count":114,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.bpg.2004.04.003","type":"journal-article","created":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T21:16:47Z","timestamp":1093641407000},"page":"717-733","source":"Crossref","is-referenced-by-count":28,"title":["Functional dyspepsia: drugs for new (and old) therapeutic targets"],"prefix":"10.1016","volume":"18","author":[{"given":"Filippo","family":"Cremonini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Delgado-Aros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Talley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4 Pt 1","key":"10.1016\/j.bpg.2004.04.003_BIB1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/0016-5085(92)90764-P","article-title":"Dyspepsia and dyspepsia subgroups: a population-based study","volume":"102","author":"Talley","year":"1992","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00004836-200104000-00004","article-title":"Therapeutic options in nonulcer dyspepsia","volume":"32","author":"Talley","year":"2001","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2004.04.003_BIB3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF02064375","article-title":"Impact of functional dyspepsia on quality of life","volume":"40","author":"Talley","year":"1995","journal-title":"Digestive Diseases and Sciences"},{"issue":"5","key":"10.1016\/j.bpg.2004.04.003_BIB4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2165\/00019053-199201050-00003","article-title":"Economic costs of functional dyspepsia","volume":"1","author":"Nyren","year":"1992","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.bpg.2004.04.003_BIB5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-108-6-865","article-title":"Non-ulcer dyspepsia: potential causes and pathophysiology","volume":"108","author":"Talley","year":"1988","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.bpg.2004.04.003_BIB6","first-page":"CD001960","article-title":"Pharmacological interventions for non-ulcer dyspepsia [update of Cochrane Database Syst Rev. 2000;(2):CD001960; PMID: 10796840]","author":"Moayyedi","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"supplement 50","key":"10.1016\/j.bpg.2004.04.003_BIB7","first-page":"iv36, iv41","article-title":"The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies","volume":"4","author":"Talley","year":"2002","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.bpg.2004.04.003_BIB8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.1995.tb00359.x","article-title":"Review article: functional dyspepsia\u2014should treatment be targeted on disturbed physiology?","volume":"9","author":"Talley","year":"1995","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"2","key":"10.1016\/j.bpg.2004.04.003_BIB9","doi-asserted-by":"crossref","first-page":"G309","DOI":"10.1152\/ajpgi.00242.2002","article-title":"Acid infusion enhances duodenal mechanosensitivity in healthy subjects","volume":"285","author":"Simren","year":"2003","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.bpg.2004.04.003_BIB10","article-title":"Influence of duodenal acidification on the sensorimotor function of the proximal stomach in man","author":"Lee","year":"2003","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"6 Pt 1","key":"10.1016\/j.bpg.2004.04.003_BIB11","first-page":"G1501","article-title":"Duodenal acid-induced gastric relaxation is mediated by multiple pathways","volume":"276","author":"Lu","year":"1999","journal-title":"American Journal of Physiology"},{"issue":"11","key":"10.1016\/j.bpg.2004.04.003_BIB12","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","article-title":"Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies)","volume":"12","author":"Talley","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/gut.51.4.502","article-title":"Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients","volume":"51","author":"Wong","year":"2002","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2004.04.003_BIB14","first-page":"CD002096","article-title":"Eradication of Helicobacter pylori for non-ulcer dyspepsia [update of Cochrane Database Syst Rev. 2001;(1):CD002096; PMID: 11279751]","author":"Moayyedi","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1016\/j.bpg.2004.04.003_BIB15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7326\/0003-4819-139-6-200309160-00011","article-title":"Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori","volume":"139","author":"Sjolund","year":"2003","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.bpg.2004.04.003_BIB16","first-page":"1","article-title":"Gastroesophageal reflux disease and Helicobacter pylori infection","volume":"3","author":"Vakil","year":"2003","journal-title":"Rev Gastroenterol Disord"},{"issue":"6","key":"10.1016\/j.bpg.2004.04.003_BIB17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/00365529709025095","article-title":"Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia [comment]","volume":"32","author":"Gilvarry","year":"1997","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB18","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1053\/gast.1996.v110.pm8612991","article-title":"Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia","volume":"110","author":"Stanghellini","year":"1996","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bpg.2004.04.003_BIB19","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/j.1572-0241.1999.01281.x","article-title":"Predominant symptoms identify different subgroups in functional dyspepsia","volume":"94","author":"Stanghellini","year":"1999","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1016\/j.bpg.2004.04.003_BIB20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00004836-198912000-00005","article-title":"Lack of association between gastric emptying of solids and symptoms in nonulcer dyspepsia","volume":"11","author":"Talley","year":"1989","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1572-0241.2003.07389.x","article-title":"Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia","volume":"94","author":"Sarnelli","year":"2003","journal-title":"American Journal of Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB22","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/gast.2003.50155","article-title":"Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia","volume":"124","author":"Fischler","year":"2003","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2004.04.003_BIB23","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1572-0241.2001.03683.x","article-title":"Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia?","volume":"96","author":"Talley","year":"2001","journal-title":"American Journal of Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2004.04.003_BIB24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF01540334","article-title":"Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride","volume":"34","author":"Jian","year":"1989","journal-title":"Digestive Diseases and Sciences"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/00365529309090256","article-title":"A study of gastric emptying in non-ulcer dyspepsia using a new ultrasonographic method","volume":"28","author":"Duan","year":"1993","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.bpg.2004.04.003_BIB26","first-page":"623","article-title":"Clinical trial on the effect of domperidone on non-ulcer dyspepsia","volume":"83","author":"Sarin","year":"1986","journal-title":"Indian Journal of Medical Research"},{"issue":"2","key":"10.1016\/j.bpg.2004.04.003_BIB27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/gut.42.2.243","article-title":"Effect of gastric acid suppressants on human gastric motility","volume":"42","author":"Parkman","year":"1998","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2004.04.003_BIB28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2165\/00003495-199447010-00008","article-title":"Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders","volume":"47","author":"Wiseman","year":"1994","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.bpg.2004.04.003_BIB29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0002-9270(00)02314-5","article-title":"Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis","volume":"96","author":"Veldhuyzen van Zanten","year":"2001","journal-title":"American Journal of Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM199607253350416","article-title":"Cisapride and fatal arrhythmia","volume":"335","author":"Wysowski","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"4 Pt 1","key":"10.1016\/j.bpg.2004.04.003_BIB31","first-page":"G665","article-title":"Contractile mechanisms of action of gastroprokinetic agents: cisapride, metoclopramide, and domperidone","volume":"266","author":"Orihata","year":"1994","journal-title":"American Journal of Physiology"},{"issue":"6","key":"10.1016\/j.bpg.2004.04.003_BIB32","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2165\/00003495-199345060-00005","article-title":"Functional dyspepsia. Current treatment recommendations","volume":"45","author":"Holtmann","year":"1993","journal-title":"Drugs"},{"issue":"6442","key":"10.1016\/j.bpg.2004.04.003_BIB33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bmj.289.6442.397","article-title":"Metoclopramide and tardive dyskinesia in the elderly","volume":"289","author":"Orme","year":"1984","journal-title":"British Medical Journal Clinical Research Edition"},{"issue":"2","key":"10.1016\/j.bpg.2004.04.003_BIB34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000065589","article-title":"Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia. A randomized, controlled follow-up study","volume":"66","author":"Alizadeh-Naeeni","year":"2002","journal-title":"Digestion"},{"issue":"1\u20132","key":"10.1016\/j.bpg.2004.04.003_BIB35","first-page":"97","article-title":"The effect of metoclopramide on antral emptying of a semisolid meal in patients with functional dyspepsia. A randomized placebo controlled sonographic study","volume":"36","author":"Dumitrascu","year":"1998","journal-title":"Romanian Journal of Internal Medicine"},{"issue":"1","key":"10.1016\/j.bpg.2004.04.003_BIB36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/00365529409090434","article-title":"Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial","volume":"29","author":"Fumagalli","year":"1994","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB37","first-page":"553","article-title":"Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia","volume":"14","author":"Archimandritis","year":"1992","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"10.1016\/j.bpg.2004.04.003_BIB38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2036.2003.01641.x","article-title":"The effect of metoclopramide on QT dynamicity: double-blind, placebo-controlled, cross-over study in healthy male volunteers","volume":"18","author":"Ellidokuz","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"5","key":"10.1016\/j.bpg.2004.04.003_BIB39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2165\/00003495-198224050-00002","article-title":"Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic","volume":"24","author":"Brogden","year":"1982","journal-title":"Drugs"},{"issue":"supplement 1","key":"10.1016\/j.bpg.2004.04.003_BIB40","first-page":"7","article-title":"Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility by intraluminal manometry","volume":"55","author":"Weihrauch","year":"1979","journal-title":"Postgraduate Medical Journal"},{"issue":"supplement 1","key":"10.1016\/j.bpg.2004.04.003_BIB41","first-page":"15","article-title":"The effect of domperidone on pyloric activity in dog and in man","volume":"55","author":"Platteborse","year":"1979","journal-title":"Postgraduate Medical Journal"},{"issue":"1","key":"10.1016\/j.bpg.2004.04.003_BIB42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01318363","article-title":"Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy","volume":"30","author":"Horowitz","year":"1985","journal-title":"Digestive Diseases and Sciences"},{"issue":"3","key":"10.1016\/j.bpg.2004.04.003_BIB43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/gut.35.3.327","article-title":"Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients","volume":"35","author":"Troncon","year":"1994","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.bpg.2004.04.003_BIB44","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0016-5085(98)70012-5","article-title":"Role of impaired gastric accommodation to a meal in functional dyspepsia","volume":"115","author":"Tack","year":"1998","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bpg.2004.04.003_BIB45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1572-0241.2002.05421.x","article-title":"The proximal stomach and postprandial symptoms in functional dyspeptics","volume":"97","author":"Boeckxstaens","year":"2002","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.bpg.2004.04.003_BIB46","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2982.2004.00497.x","article-title":"Assessment of gastric accomodation: overview and evaluation of current methods","author":"De Schepper","year":"2004","journal-title":"Neurogastroenterology and Motility"},{"issue":"6","key":"10.1016\/j.bpg.2004.04.003_BIB47","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/gut.51.6.781","article-title":"SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography","volume":"51","author":"Bouras","year":"2002","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.bpg.2004.04.003_BIB48","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1053\/gast.2001.28656","article-title":"Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function","volume":"121","author":"Boeckxstaens","year":"2001","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2004.04.003_BIB49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2982.2002.00326.x","article-title":"A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health","volume":"14","author":"Chial","year":"2002","journal-title":"Neurogastroenterology and Motility"},{"issue":"2","key":"10.1016\/j.bpg.2004.04.003_BIB50","doi-asserted-by":"crossref","first-page":"G180","DOI":"10.1152\/ajpgi.00413.2002","article-title":"Musings on the wanderer: what's new in our understanding of vago-vagal reflexes? III. Activity-dependent plasticity in vago-vagal reflexes controlling the stomach","volume":"284","author":"Travagli","year":"2003","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"Pt 2","key":"10.1016\/j.bpg.2004.04.003_BIB51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1113\/jphysiol.1995.sp020680","article-title":"Vagal control of nitric oxide and vasoactive intestinal polypeptide release in the regulation of gastric relaxation in rat","volume":"484","author":"Takahashi","year":"1995","journal-title":"Journal of Physiology"},{"issue":"6326","key":"10.1016\/j.bpg.2004.04.003_BIB52","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/351477a0","article-title":"Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid","volume":"351","author":"Desai","year":"1991","journal-title":"Nature"},{"issue":"2 Pt 1","key":"10.1016\/j.bpg.2004.04.003_BIB53","first-page":"G373","article-title":"Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus","volume":"276","author":"Coulie","year":"1999","journal-title":"American Journal of Physiology"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB54","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/gut.46.4.468","article-title":"Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man","volume":"46","author":"Tack","year":"2000","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2004.04.003_BIB55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2982.2003.00389.x","article-title":"Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials","volume":"15","author":"Cremonini","year":"2003","journal-title":"Neurogastroenterology and Motility"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2036.2001.00941.x","article-title":"A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia","volume":"15","author":"Talley","year":"2001","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"2","key":"10.1016\/j.bpg.2004.04.003_BIB57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2036.2002.01144.x","article-title":"Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans","volume":"16","author":"Kuo","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4 supplement 1","key":"10.1016\/j.bpg.2004.04.003_BIB58","first-page":"A453","article-title":"Influence of tegaserod on proximal gastric sensory and motor function in man","volume":"122","author":"Tack","year":"2002","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.bpg.2004.04.003_BIB59","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1046\/j.1365-2036.2001.01103.x","article-title":"Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects","volume":"15","author":"Degen","year":"2001","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"11","key":"10.1016\/j.bpg.2004.04.003_BIB60","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1046\/j.1365-2036.2000.00854.x","article-title":"The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease","volume":"14","author":"Kahrilas","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB61","first-page":"A20","article-title":"A phase II placebo controlled randomized trial with tegaserod in functional dyspepsia patients with normal gastric emptying","volume":"122","author":"Tack","year":"2002","journal-title":"Gastroenterology"},{"issue":"7461","key":"10.1016\/j.bpg.2004.04.003_BIB62","first-page":"465","article-title":"Fatty foods and dyspersia","volume":"2","author":"Taggart","year":"1966","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.bpg.2004.04.003_BIB63","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00042737-199511000-00007","article-title":"Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsia","volume":"7","author":"Barbera","year":"1995","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"3 Pt 1","key":"10.1016\/j.bpg.2004.04.003_BIB64","first-page":"G721","article-title":"Effects of duodenal nutrients on sensory and motor responses of the human stomach to distension","volume":"273","author":"Feinle","year":"1997","journal-title":"American Journal of Physiology"},{"issue":"5","key":"10.1016\/j.bpg.2004.04.003_BIB65","doi-asserted-by":"crossref","first-page":"R1217","DOI":"10.1152\/ajpregu.2000.278.5.R1217","article-title":"Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans","volume":"278","author":"Feinle","year":"2000","journal-title":"American Journal of Physiology. Regulatory Integrative and Comparative Physiology"},{"issue":"10","key":"10.1016\/j.bpg.2004.04.003_BIB66","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0899-9007(00)00419-6","article-title":"Cholecystokinin and satiety: current perspectives","volume":"16","author":"Moran","year":"2000","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.bpg.2004.04.003_BIB67","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.48.3.347","article-title":"Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia","volume":"48","author":"Feinle","year":"2001","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.bpg.2004.04.003_BIB68","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2165\/00003495-200363090-00003","article-title":"New developments in the treatment of functional dyspepsia","volume":"63","author":"Stanghellini","year":"2003","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.bpg.2004.04.003_BIB69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11916-003-0005-5","article-title":"Opioids: a review","volume":"7","author":"Chevlen","year":"2003","journal-title":"Current Pain and Headache Reports"},{"issue":"7","key":"10.1016\/j.bpg.2004.04.003_BIB70","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003495-200363070-00003","article-title":"Opioid-induced bowel dysfunction: pathophysiology and potential new therapies","volume":"63","author":"Kurz","year":"2003","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.bpg.2004.04.003_BIB71","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1365-2036.1996.109280000.x","article-title":"Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans","volume":"10","author":"Coffin","year":"1996","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"5","key":"10.1016\/j.bpg.2004.04.003_BIB72","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/gut.41.5.664","article-title":"Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia","volume":"41","author":"Read","year":"1997","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.bpg.2004.04.003_BIB73","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/BF02209014","article-title":"Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study","volume":"40","author":"Dapoigny","year":"1995","journal-title":"Digestive Diseases and Sciences"},{"issue":"1","key":"10.1016\/j.bpg.2004.04.003_BIB74","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0016-5085(99)70226-X","article-title":"The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome","volume":"116","author":"Delvaux","year":"1999","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB75","doi-asserted-by":"crossref","first-page":"G558","DOI":"10.1152\/ajpgi.00360.2002","article-title":"Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans","volume":"284","author":"Delgado-Aros","year":"2003","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"13","key":"10.1016\/j.bpg.2004.04.003_BIB76","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJMoa010564","article-title":"Selective postoperative inhibition of gastrointestinal opioid receptors","volume":"345","author":"Taguchi","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.bpg.2004.04.003_BIB77","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0304-3959(91)90100-C","article-title":"The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states","volume":"44","author":"Woolf","year":"1991","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.bpg.2004.04.003_BIB78","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1046\/j.1365-2036.2002.01358.x","article-title":"Effect of the low-affinity, noncompetitive N-methyl-d-aspartate receptor antagonist dextromethorphan on visceral perception in healthy volunteers","volume":"16","author":"Kuiken","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.bpg.2004.04.003_BIB79","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2165\/00002018-199207030-00004","article-title":"Dextromethorphan. An overview of safety issues","volume":"7","author":"Bem","year":"1992","journal-title":"Drug Safety"},{"issue":"3","key":"10.1016\/j.bpg.2004.04.003_BIB80","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0163-7258(96)00195-7","article-title":"Tachykinins in the gut. Part I. Expression, release and motor function","volume":"73","author":"Holzer","year":"1997","journal-title":"Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.bpg.2004.04.003_BIB81","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0163-7258(96)00196-9","article-title":"Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation","volume":"73","author":"Holzer","year":"1997","journal-title":"Pharmacology and Therapeutics"},{"issue":"12","key":"10.1016\/j.bpg.2004.04.003_BIB82","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1002\/cncr.11433","article-title":"Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America","volume":"97","author":"Poli-Bigelli","year":"2003","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.bpg.2004.04.003_BIB83","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/cncr.11320","article-title":"Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting","volume":"97","author":"Chawla","year":"2003","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB84","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2982.2003.00420.x","article-title":"Intestinal anti-nociceptive behaviour of NK3 receptor antagonism in conscious rats: evidence to support a peripheral mechanism of action","volume":"15","author":"Fioramonti","year":"2003","journal-title":"Neurogastroenterology and Motility"},{"issue":"8","key":"10.1016\/j.bpg.2004.04.003_BIB85","first-page":"758","article-title":"Antagonists at the neurokinin receptors-recent patent literature","volume":"6","author":"Giardina","year":"2003","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.bpg.2004.04.003_BIB86","first-page":"143","article-title":"Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons","volume":"43","author":"Holzer","year":"1991","journal-title":"Pharmacological Reviews"},{"issue":"1\u20132","key":"10.1016\/j.bpg.2004.04.003_BIB87","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0006-8993(95)01094-7","article-title":"Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment","volume":"703","author":"Szallasi","year":"1995","journal-title":"Brain Research"},{"issue":"6","key":"10.1016\/j.bpg.2004.04.003_BIB88","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.1365-2036.2002.01280.x","article-title":"The treatment of functional dyspepsia with red pepper","volume":"16","author":"Bortolotti","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/j.bpg.2004.04.003_BIB89","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-2036.2000.00682.x","article-title":"The effects of capsaicin on reflux, gastric emptying and dyspepsia","volume":"14","author":"Rodriguez-Stanley","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"5","key":"10.1016\/j.bpg.2004.04.003_BIB90","doi-asserted-by":"crossref","first-page":"G787","DOI":"10.1152\/ajpgi.2001.280.5.G787","article-title":"Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents","volume":"280","author":"Kirkup","year":"2001","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"1-3","key":"10.1016\/j.bpg.2004.04.003_BIB91","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-2999(01)01319-X","article-title":"Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain","volume":"429","author":"Holzer","year":"2001","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.bpg.2004.04.003_BIB92","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2165\/00003495-199142050-00002","article-title":"The use of antidepressants in the treatment of chronic pain. A review of the current evidence","volume":"42","author":"Magni","year":"1991","journal-title":"Drugs"},{"issue":"3 Pt 1","key":"10.1016\/j.bpg.2004.04.003_BIB93","first-page":"G460","article-title":"Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans","volume":"275","author":"Gorelick","year":"1998","journal-title":"American Journal of Physiology"},{"issue":"2","key":"10.1016\/j.bpg.2004.04.003_BIB94","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1572-0241.1998.00160.x","article-title":"Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia","volume":"93","author":"Mertz","year":"1998","journal-title":"American Journal of Gastroenterology"},{"issue":"20","key":"10.1016\/j.bpg.2004.04.003_BIB95","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM199405193302003","article-title":"Imipramine in patients with chest pain despite normal coronary angiograms [comment]","volume":"330","author":"Cannon","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.bpg.2004.04.003_BIB96","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00299-5","article-title":"Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis","volume":"108","author":"Jackson","year":"2000","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1016\/j.bpg.2004.04.003_BIB97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00634443","article-title":"Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study","volume":"99","author":"Loldrup","year":"1989","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB98","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/00365529609006404","article-title":"A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin","volume":"31","author":"Tanum","year":"1996","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"9298","key":"10.1016\/j.bpg.2004.04.003_BIB99","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(01)07103-3","article-title":"Serotoninergic neuroenteric modulators","volume":"358","author":"Talley","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2004.04.003_BIB100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1192\/bjp.178.2.129","article-title":"Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials [comment]","volume":"178","author":"Barbui","year":"2001","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB101","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2982.2002.00344.x","article-title":"Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans","volume":"14","author":"Ladabaum","year":"2002","journal-title":"Neurogastroenterology and Motility"},{"issue":"4","key":"10.1016\/j.bpg.2004.04.003_BIB102","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2003.01469.x","article-title":"Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans","volume":"17","author":"Tack","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.bpg.2004.04.003_BIB103","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1542-3565(03)70038-X","article-title":"Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans","volume":"1","author":"Chial","year":"2003","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"3","key":"10.1016\/j.bpg.2004.04.003_BIB104","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1542-3565(03)70039-1","article-title":"The selective serotonin reuptake inhibitor fluoxetine does not change rectaql sensitivity and symptoms in patients with irritable bowel syndrome: a double-blind, randomized placebo-controlled study","volume":"1","author":"Kuiken","year":"2003","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"3","key":"10.1016\/j.bpg.2004.04.003_BIB105","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1067\/mhj.2000.108514","article-title":"Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin","volume":"140","author":"Varia","year":"2000","journal-title":"American Heart Journal"},{"issue":"447","key":"10.1016\/j.bpg.2004.04.003_BIB106","first-page":"787","article-title":"Patients with irritable bowel syndrome: health status and use of health care services","volume":"49","author":"Donker","year":"1999","journal-title":"British Journal of General Practice"},{"issue":"7","key":"10.1016\/j.bpg.2004.04.003_BIB107","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/gut.27.7.826","article-title":"Alternative medicine consultations and remedies in patients with the irritable bowel syndrome","volume":"27","author":"Smart","year":"1986","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.bpg.2004.04.003_BIB108","first-page":"121","article-title":"Use of alternative medicine by patients attending a gastroenterology clinic","volume":"142","author":"Verhoef","year":"1990","journal-title":"CMAJ Canadian Medical Association Journal"},{"issue":"6","key":"10.1016\/j.bpg.2004.04.003_BIB109","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1365-2036.2003.01498.x","article-title":"Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia","volume":"17","author":"Koloski","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.bpg.2004.04.003_BIB110","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0016-5085(88)80017-9","article-title":"Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome","volume":"95","author":"Drossman","year":"1988","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2004.04.003_BIB111","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0016-5085(84)90706-6","article-title":"Symptom complaints and health care seeking behavior in subjects with bowel dysfunction","volume":"87","author":"Sandler","year":"1984","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2004.04.003_BIB112","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1572-0241.2001.03789.x","article-title":"Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors","volume":"96","author":"Koloski","year":"2001","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2004.04.003_BIB113","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/gast.2000.16493","article-title":"A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia","volume":"119","author":"Hamilton","year":"2000","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.bpg.2004.04.003_BIB114","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.37071","article-title":"Long-term improvement in functional dyspepsia using hypnotherapy","volume":"123","author":"Calvert","year":"2002","journal-title":"Gastroenterology"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691804000356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691804000356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T01:57:18Z","timestamp":1585879038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691804000356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S1521691804000356"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2004.04.003","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}